{"url":"https://lda.gov/api/v1/filings/f1b7635e-77a6-454f-ac45-249ca486450d/","filing_uuid":"f1b7635e-77a6-454f-ac45-249ca486450d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/f1b7635e-77a6-454f-ac45-249ca486450d/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Anthony Campau","dt_posted":"2026-04-18T12:06:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1001 Pennsylvania Avenue NW, Suite 1300S","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401106670,"url":"https://lda.gov/api/v1/registrants/401106670/","house_registrant_id":45635,"name":"CLARK HILL PUBLIC STRATEGIES LLC","description":null,"address_1":"1001 Pennsylvania Avenue NW, Suite 1300S","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANTHONY CAMPAU","contact_telephone":"+1 240-331-8804","dt_updated":"2026-07-17T13:00:21.626343-04:00"},"client":{"id":64539,"url":"https://lda.gov/api/v1/clients/64539/","client_id":64539,"name":"WEST PHARMACEUTICAL SERVICES, INC.","general_description":"Pharmaceuticals","client_government_entity":null,"client_self_select":false,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-24"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Matters relating to the pharmaceutical manufacturing and supply chain security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147877,"prefix":null,"prefix_display":null,"first_name":"CONRAD","nickname":null,"middle_name":null,"last_name":"FURLICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144750,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"CAMPAU","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff and Counselor, Office of Information and Regulatory Affairs (OIRA), U.S. Office of Management and Budget (OMB), Executive Office of the President (EOP); Transition Staff, OMB/OIRA; Regulatory Reform Team, Presidential Transition Team.","new":false},{"lobbyist":{"id":151842,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"ALEKSANYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Matters relating to the pharmaceutical manufacturing and supply chain security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147877,"prefix":null,"prefix_display":null,"first_name":"CONRAD","nickname":null,"middle_name":null,"last_name":"FURLICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144750,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"CAMPAU","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff and Counselor, Office of Information and Regulatory Affairs (OIRA), U.S. Office of Management and Budget (OMB), Executive Office of the President (EOP); Transition Staff, OMB/OIRA; Regulatory Reform Team, Presidential Transition Team.","new":false},{"lobbyist":{"id":151842,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"ALEKSANYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Matters relating to the pharmaceutical manufacturing and supply chain security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147877,"prefix":null,"prefix_display":null,"first_name":"CONRAD","nickname":null,"middle_name":null,"last_name":"FURLICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144750,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"CAMPAU","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff and Counselor, Office of Information and Regulatory Affairs (OIRA), U.S. Office of Management and Budget (OMB), Executive Office of the President (EOP); Transition Staff, OMB/OIRA; Regulatory Reform Team, Presidential Transition Team.","new":false},{"lobbyist":{"id":151842,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"ALEKSANYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}